True Private Wealth Advisors Inmune Bio, Inc. Transaction History

True Private Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 11, 2021	SELL	$7.51 - $17.22 $7,510 - $17,220	-1,000 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$3.56 - $6.1 $3,560 - $6,100	1,000 New	1,000 $5,000
Q3 2019 Oct 09, 2019	SELL	$5.32 - $10.0 $5,320 - $10,000	-1,000 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$7.45 - $11.0 $7,450 - $11,000	1,000 New	1,000 $9,000

2.88M

44.6K

3.5K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $145M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.